Hao‐Wen Sim

1.5k total citations
73 papers, 931 citations indexed

About

Hao‐Wen Sim is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Genetics. According to data from OpenAlex, Hao‐Wen Sim has authored 73 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 24 papers in Cancer Research and 23 papers in Genetics. Recurrent topics in Hao‐Wen Sim's work include Glioma Diagnosis and Treatment (23 papers), Cancer Genomics and Diagnostics (13 papers) and Renal cell carcinoma treatment (12 papers). Hao‐Wen Sim is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Cancer Genomics and Diagnostics (13 papers) and Renal cell carcinoma treatment (12 papers). Hao‐Wen Sim collaborates with scholars based in Australia, Canada and United States. Hao‐Wen Sim's co-authors include Jennifer J. Knox, Ann McCormack, Mustafa Khasraw, Michael E. Buckland, Warren Mason, Evanthia Galanis, Erin R. Morgan, Brindha Shivalingam, Kimberley L. Alexander and Joanne Sy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hao‐Wen Sim

67 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hao‐Wen Sim Australia	17	364	327	326	299	162	73	931
Edgardo S. Santos United States	21	384 1.1×	524 1.6×	576 1.8×	230 0.8×	81 0.5×	101	1.2k
Jaymes Holland United States	14	294 0.8×	299 0.9×	259 0.8×	143 0.5×	220 1.4×	25	769
Adrian Langleben Canada	17	316 0.9×	416 1.3×	725 2.2×	158 0.5×	114 0.7×	55	1.1k
Johanna W. Wilmink Netherlands	17	569 1.6×	253 0.8×	736 2.3×	402 1.3×	128 0.8×	51	1.3k
Amy K. Kim United States	12	269 0.7×	216 0.7×	263 0.8×	237 0.8×	181 1.1×	28	976
Kevin Yee United States	9	480 1.3×	362 1.1×	303 0.9×	135 0.5×	267 1.6×	12	1.2k
Naseem J. Zojwalla United States	15	429 1.2×	275 0.8×	404 1.2×	481 1.6×	46 0.3×	26	948
Véronique D’Hondt France	21	298 0.8×	335 1.0×	781 2.4×	241 0.8×	99 0.6×	83	1.3k
Guoshuang Shen China	14	298 0.8×	356 1.1×	538 1.7×	219 0.7×	30 0.2×	61	1000
Regula Deurloo Switzerland	5	316 0.9×	215 0.7×	468 1.4×	222 0.7×	61 0.4×	12	947

Countries citing papers authored by Hao‐Wen Sim

Since Specialization

Citations

This map shows the geographic impact of Hao‐Wen Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao‐Wen Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao‐Wen Sim more than expected).

Fields of papers citing papers by Hao‐Wen Sim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao‐Wen Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao‐Wen Sim. The network helps show where Hao‐Wen Sim may publish in the future.

Co-authorship network of co-authors of Hao‐Wen Sim

This figure shows the co-authorship network connecting the top 25 collaborators of Hao‐Wen Sim. A scholar is included among the top collaborators of Hao‐Wen Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao‐Wen Sim. Hao‐Wen Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Satgunaseelan, Laveniya, Maggie Lee, Susannah Hallal, et al.. (2024). ‘The Reports of My Death Are Greatly Exaggerated’—Evaluating the Effect of Necrosis on MGMT Promoter Methylation Testing in High-Grade Glioma. Cancers. 16(10). 1906–1906. 1 indexed citations

Hallal, Susannah, Brindha Shivalingam, Hao‐Wen Sim, et al.. (2024). Size matters: Biomolecular compositions of small and large extracellular vesicles in the urine of glioblastoma patients. SHILAP Revista de lepidopterología. 3(11). e70021–e70021. 2 indexed citations

Jiang, Di, Hao‐Wen Sim, Lillian L. Siu, et al.. (2023). Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. Clinical Colorectal Cancer. 22(4). 457–463.

Lee, Yeh Chen, Hao‐Wen Sim, Judy Kirk, et al.. (2023). Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. Translational Oncology. 31. 101638–101638.

Satgunaseelan, Laveniya, Joanne Sy, Brindha Shivalingam, et al.. (2023). Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play. Pathology. 56(2). 158–169. 6 indexed citations

Gan, Hui, Bryan W. Day, Rosemary Harrup, et al.. (2023). Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. Current Oncology Reports. 25(6). 589–598. 3 indexed citations

Sim, Hao‐Wen, Selena Lorrey, & Mustafa Khasraw. (2023). Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas. Current Neurology and Neuroscience Reports. 23(6). 263–276. 5 indexed citations

Doherty, Mark, Vincent C. Tam, Mairéad G. McNamara, et al.. (2022). Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer. British Journal of Cancer. 127(8). 1473–1478. 7 indexed citations

Halkett, Georgia, Lauren J. Breen, Hao‐Wen Sim, et al.. (2022). Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers. Current Oncology. 29(12). 9928–9955.

10.

Kong, Benjamin Y., Hao‐Wen Sim, Elizabeth H Barnes, et al.. (2022). Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma. BMJ Open. 12(9). e058107–e058107. 4 indexed citations

11.

Lee, Yeh Chen, Hao‐Wen Sim, Tanya Chawla, et al.. (2022). Interobserver and intraobserver variability of RECIST assessment in ovarian cancer. International Journal of Gynecological Cancer. 32(5). 656–661. 7 indexed citations

12.

Hecht, J. Randolph, Sara Lonardi, Johanna C. Bendell, et al.. (2021). Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Journal of Clinical Oncology. 39(10). 1108–1118. 78 indexed citations

13.

Hallal, Susannah, Heng Wei, Hao‐Wen Sim, et al.. (2020). Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients. International Journal of Molecular Sciences. 21(14). 4954–4954. 38 indexed citations

14.

Hallal, Susannah, Heng Wei, Nicholas Ho, et al.. (2020). A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance. International Journal of Molecular Sciences. 21(13). 4754–4754. 41 indexed citations

15.

Lee‐Ying, Richard M., Hao‐Wen Sim, Kelvin Chan, et al.. (2020). Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database. Cancer Medicine. 9(14). 4918–4928. 11 indexed citations

16.

Sim, Hao‐Wen, Romina Nejad, Wenjiang Zhang, et al.. (2019). Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas. Clinical Cancer Research. 25(11). 3366–3373. 21 indexed citations

17.

Khasraw, Mustafa, Kerrie L. McDonald, Mark Rosenthal, et al.. (2019). A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY. Neuro-Oncology. 21. 18–18. 1 indexed citations

18.

Mitchell, Laura E., Jeremy Lewin, Amirrtha Srikanthan, et al.. (2018). Measuring the Impact of an Adolescent and Young Adult Program on Addressing Patient Care Needs. Journal of Adolescent and Young Adult Oncology. 7(5). 612–617. 18 indexed citations

19.

Lewin, Jeremy, Swati Garg, Brendan C. Dickson, et al.. (2017). Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma. International Journal of Cancer. 142(1). 57–65. 23 indexed citations

20.

Yip, Steven, Frede Donskov, Anna Paola Fraccon, et al.. (2017). Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC). PubMed. 1(1). 41–47. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact